Engineered Nanobody Drug Tames Inflammation by Rewiring IL-10 Receptor Geometry
Scientists have engineered a tetravalent nanobody agonist that harnesses differential TYK2 dependence and receptor abundance to deliver IL-10's anti-inflammatory power ...

